Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARCUS C REEVES

Allopathic & Osteopathic Physicians Family Medicine

NPI
1457314007
CMS profile
111743
Location
MEMPHIS, TN

General Payments · PY2018–2024

$2,192.00

  • Reported across 131 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$293.31

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $293.31 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $358.21 23
PY2019 $296.53 20
PY2020 $249.78 16
PY2021 $290.97 17
PY2022 $448.47 25
PY2023 $254.73 14
PY2024 $293.31 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $19.82 07/30/2024 Food and Beverage Undisputed 01/23/2026 1125073546 CMS
ABBVIE INC. $19.07 08/16/2024 Food and Beverage Undisputed 01/23/2026 1105932896 CMS
Alnylam Pharmaceuticals Inc. $24.22 04/30/2024 Food and Beverage Undisputed 01/23/2026 1125851865 CMS
AstraZeneca Pharmaceuticals LP $18.00 05/14/2024 Food and Beverage Undisputed 01/23/2026 1104388783 CMS
AstraZeneca Pharmaceuticals LP $14.49 10/31/2024 Food and Beverage Undisputed 01/23/2026 1105514745 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.86 07/12/2024 Food and Beverage Undisputed 01/23/2026 1118015630 CMS
Exeltis, USA Inc. $14.70 08/28/2024 Food and Beverage Undisputed 01/23/2026 1150002786 CMS
Exeltis, USA Inc. $13.73 11/21/2024 Food and Beverage Undisputed 01/23/2026 1150002788 CMS
Ipsen Biopharmaceuticals, Inc $16.41 07/15/2024 Food and Beverage Undisputed 01/23/2026 1091988113 CMS
Lilly USA, LLC $23.23 02/16/2024 Food and Beverage Undisputed 01/23/2026 1135107755 CMS
Lilly USA, LLC $14.62 06/13/2024 Food and Beverage Undisputed 01/23/2026 1135157585 CMS
Lilly USA, LLC $14.43 08/12/2024 Food and Beverage Undisputed 01/23/2026 1135157587 CMS
Lilly USA, LLC $15.20 11/19/2024 Food and Beverage Undisputed 01/23/2026 1135152066 CMS
Novo Nordisk Inc $15.85 07/18/2024 Food and Beverage Undisputed 01/23/2026 1096956471 CMS
SANOFI-AVENTIS U.S. LLC $29.90 09/23/2024 Food and Beverage Undisputed 01/23/2026 1139684113 CMS
SANOFI-AVENTIS U.S. LLC $22.78 11/05/2024 Food and Beverage Undisputed 01/23/2026 1139684127 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.